Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls

J Invest Dermatol. 2015 Jul;135(7):1-5. doi: 10.1038/jid.2015.171.

Authors

Juul M P A van den Reek¹, Wietske Kievit², Robert Gniadecki³, Jelle J Goeman², Jeffrey Zweegers⁴, Peter C M van de Kerkhof⁴, Marieke M B Seyger⁴, Elke M G J de Jong⁴

Affiliations

¹ Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Juul.vandenReek@Radboudumc.nl.
² Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Department of Dermatology, Bispebjerg Hospital, Bispebjerg, Denmark.
⁴ Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.

PMID: 26066896
DOI: 10.1038/jid.2015.171

No abstract available

Publication types

Review

MeSH terms

Biological Products / administration & dosage
Biological Products / adverse effects
Biological Products / pharmacology
Dermatologic Agents / administration & dosage*
Dermatologic Agents / adverse effects
Dermatologic Agents / pharmacology
Dermatology / standards
Dermatology / trends
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug-Related Side Effects and Adverse Reactions*
Female
Humans
Kaplan-Meier Estimate
Male
Maximum Tolerated Dose
Melanoma / diagnosis
Melanoma / drug therapy
Melanoma / mortality
Netherlands
Patient Safety
Proportional Hazards Models
Psoriasis / drug therapy
Risk Assessment
Skin Diseases / diagnosis
Skin Diseases / drug therapy*
Skin Diseases / mortality
Survival Analysis

Substances

Biological Products
Dermatologic Agents